NCT05200182

Brief Summary

Emotional overeating is characterized by an excessive food intake in the context of intense emotional situations, such as acute stress one. Emotional overeating, as a behavioral trait, can increase the risk of to develop eating disorders or eating-related diseases, such as metabolic syndrome, obesity, type-2 diabetes. Recently, imaging modalities, such as magnetic resonance imaging (MRI) and electro-encephalography (EEG), have been adapted in order to perform neurofeedback consisting on presenting the brain activity instantaneously to the participant, that give him the possibility to modify this activity by his own mean. Neurofeedback has already shown some efficacy, either with explicit or implicit instruction. Compared with functional MRI (fMRI), functional near infra-red spectroscopy (fNIRS) is easy to handle, less expensive, and does not require a lying position. fNIRS is consequently more adapted for repeated acquisitions. Neurofeedback has already shown some promising results for neurological and psychiatric diseases. For mental states and emotion regulation, neurofeedback targeting the prefrontal cortex (PFC) has also shown promising outcomes. In this project, the investigators want to assess the effect of neurofeedback targeting the dorsolateral PFC (dlPFC) in a population of young adult women presenting emotional overeating. The investigators aim to improve the cognitive control and to reduce the episodes of emotional overeating in order to prevent the occurrence of subsequent pathologies. The intervention effect will be characterized with: (i) fMRI in order to evaluate the effect on cognitive control (with resting state fMRI or rsMRI) and on the reward system; (II) questionaries directly and one month after intervention in order to assess the behavioral effect. Besides an expected effect on emotional overeating, the investigators will evaluate whether an improvement of cognitive control can also promote positive effect on other behavioral traits that could lead to some pathologies such as food addiction. As a prerequisite to this study on emotional overeating (study B), the investigators will firstly validate on healthy subjects (study A) a reward anticipation fMRI task, which will be further used in study A in order to characterized the effect of neurofeedback on the reward system.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 6, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 20, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

April 7, 2022

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

3.1 years

First QC Date

January 6, 2022

Last Update Submit

April 9, 2024

Conditions

Keywords

emotional overeatingfunctional near infraRed spectroscopyneurofeedbackcognitive control

Outcome Measures

Primary Outcomes (1)

  • Change in cortico-striatal connectivity

    Significant change in cortico-striatal connectivity as determined with resting state functional magnetic resonance imaging correlation coefficient between the first magnetic resonance imaging and the last magnetic resonance imaging visit

    4 weeks

Study Arms (3)

Study A

OTHER

Validation of the reward system-related fMRI task, as determined by an increased activation on the brain reward structure (striatum) under the task.

Device: Neurofeedback with functional near infra-red spectroscopyDevice: resting-state fMRIDevice: Electro gastrogram

Study B - Neurofeedback

EXPERIMENTAL

The neurofeedback protocol will be the same during the 8 sessions constituting the protocol and taking place over a period of 4 weeks (2 neurofeedback sessions per week, the first and the last one in an MRI context). It will last 15 minutes per session, and during each session, the volunteer will have to increase the brain activity of his/her dlPFC using a visual gauge representing the "activity level" of his/her own dlPFC. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this "activity level".

Device: Neurofeedback with functional near infra-red spectroscopyOther: oral microbiota collectionOther: QuestionnairesDevice: resting-state fMRIDevice: Electro gastrogramBehavioral: Emotional Stroop task

Study B - Control

SHAM COMPARATOR

In the control group with neurofeedback sham, the participants will receive the same instruction but will be shown a random signal, the goal being that the control strategy the participant tries to implement is not correlated with the visual feedback provided by the gauge.

Device: Sham NeurofeedbackOther: oral microbiota collectionOther: QuestionnairesDevice: resting-state fMRIDevice: Electro gastrogramBehavioral: Emotional Stroop task

Interventions

the neurofeedback protocol will last 15 minutes per session, and during each session, the volunteer will have to increase the brain activity of his/her dorsolateral prefrontal cortex using a visual gauge representing the "activity level" of his/her own dorsolateral prefrontal cortex. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this "activity level".

Study AStudy B - Neurofeedback

the participants will receive the same instruction but will be shown a random signal

Study B - Control

an examination and oral swab for oral microbiota analysis will be performed by a dentist

Study B - ControlStudy B - Neurofeedback

questionnaires for pre-intervention behavioral characterization

Study B - ControlStudy B - Neurofeedback

characterize the brain function of volunteers by resting-state fMRI

Study AStudy B - ControlStudy B - Neurofeedback

Volunteers will also be equipped with an MRI-compatible electro-gastrogram device to correlate gastric signals with brain activity during rsMRI acquisition.

Study AStudy B - ControlStudy B - Neurofeedback

an emotional Stroop task adapted to food and body image representation

Study B - ControlStudy B - Neurofeedback

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Normal Body Mass Index (18.5-25),
  • Right-handlers
  • Affiliated to a social security scheme
  • Having given a free, informed and written consent

You may not qualify if:

  • Related to the study - Insufficient command of French
  • Related to Magnetic Resonance Imagine
  • Implantable cardiac pacemaker or defibrillator;
  • Neurosurgical clips;
  • Cochlear implants;
  • Neural or peripheral stimulator;
  • Foreign orbital or brain metallic foreign bodies;
  • Endoprostheses implanted for less than 4 weeks and osteosynthesis materials placed for less than 6 weeks;
  • Claustrophobia. Related to near infra Red spectroscopy
  • Hairs that do not allow proper near infra Red spectroscopy measurement upon ligh blockage
  • Study B
  • Minimum age : 18 Years
  • Maximum Age : 25 Years
  • Sex : women
  • Normal BMI (18.5-25),
  • +21 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Rennes - Pontchaillou

Rennes, 35000, France

RECRUITING

MeSH Terms

Conditions

Hyperphagia

Interventions

NeurofeedbackSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Biofeedback, PsychologyMind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, PsychologicalData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Romain Moirand, MD

    CHU Rennes

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nicolas COQUERY, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2022

First Posted

January 20, 2022

Study Start

April 7, 2022

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

April 10, 2024

Record last verified: 2024-04

Locations